Articles |
the Laboratoire de Physiologie Cellulaire (K. Le P., D.F.), CNRS ERS 100, Universite Paris XI, Orsay, France, and INSERM-Groupe DRT (D.L-G.), Faculte de Pharmacie, Rennes, France.
Correspondence to Dr D. Lagadic-Gossmann, INSERM-Groupe DRT, 2, avenue Pr. Leon Bernard, Faculte de Pharmacie, 35 043 Rennes cedex, France.
| Abstract |
|---|
|
|
|---|
58% of acid efflux in the diabetic group. This decrease was even more marked in normal cells (by
74%). Interestingly, the pHi dependence of the acid efflux carried by Na+-H+ exchange then became identical in both groups of cells, thus pointing to a role for intracellular Ca2+ in the diabetes-related alterations of the exchange. Inhibition of calmodulin (by 1.5 µmol/L calmidazolium) and of Ca2+/calmodulin-dependent protein kinase II (by 2 µmol/L 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine [KN-62]) significantly slowed down pHi recovery in both normal and diabetic cells. However, the effect of KN-62 was significantly lower in diabetic cells (efflux decreased by
17%) compared with normal cells (decrease by 45%). In conclusion, these data, in light of recent observations showing a decreased [Ca2+]i associated with diabetes in isolated ventricular myocytes, suggest that changes in intracellular Ca2+ may play an important role in altering Na+-H+ exchange activity in diabetic ventricular myocytes. They also point to diabetes-related alterations in the Ca2+/calmodulin protein kinase IIdependent phosphorylation of Na+-H+ exchange.
Key Words: Na+-H+ exchange ventricular myocyte diabetes intracellular Ca2+ pHo
| Introduction |
|---|
|
|
|---|
In the present work, we investigated the modulation by extracellular H+ and intracellular Ca2+ of pHi recovery due to Na+-H+ exchange in myocytes isolated from normal and STZ-induced diabetic rat hearts. To this purpose, pHi was recorded using the intracellular fluoroprobe carboxy-SNARF-1, and the different solutions were buffered with HEPES in order to turn off the bicarbonate-dependent pHi-regulating mechanisms, especially the Na+-HCO3- symport.17 ßi, which is needed when calculating acid effluxes,18 was estimated and compared between both groups. We also tested the effects of calmidazolium, an inhibitor of calmodulin,19 and the effects of KN-62, an inhibitor of Ca2+/CaM kinase II,20 21 on the activity of Na+-H+ exchange.
| Materials and Methods |
|---|
|
|
|---|
Male Wistar rats weighing 150 to 180 g were fasted overnight and made diabetic by an injection of STZ (40 mg/kg, Sigma Chemical Co) into the femoral vein. STZ-treated and age-matched control animals were maintained on the same diet until they were used 3 to 4 weeks later. This period of diabetes was chosen because previous studies have characterized cardiac alterations during this period.4 6 16 22 The diabetic state was assessed by measurement of nonfasting glucose concentration in blood samples collected at the time of heart excision. Mean glucose levels were 10.2±0.3 and 45.9±2.4 mmol/L for normal rats (n=20) and diabetic rats (n=20), respectively.
Isolation of Rat Ventricular Myocytes
Briefly, single ventricular myocytes were obtained from the hearts of rats (anesthetized with 50 mg·kg-1 body wt IP pentothal) using a combination of enzymatic (0.28 mg/mL collagenase, Yakult; 0.05 mg/mL protease type XIV, Sigma) and mechanical dispersion. The composition of the basic solution and further details of the procedure have been described previously.22 Ca2+-tolerant rod-shaped ventricular myocytes were used on the day of isolation.
Experimental Solutions and Chemicals
HEPES-buffered Tyrode's solution contained (mmol/L) NaCl 140, KCl 5.4, CaCl2 1, MgCl2 1.2, glucose 11, and HEPES 10, with pH adjusted to 7.4 at 37°C with NaOH. In Na+-free Tyrode's solution, NaCl was replaced with 140 mmol/L N-methyl-D-glucamine, and the pH was adjusted to 7.4 at 37°C with HCl. When Tyrode's solution with a pH of 8.0 or 6.8 was needed, HEPPS or PIPES buffer was used in replacement of the HEPES buffer. Ammonium chloride (Sigma) was added directly to solutions shortly before use. Addition and then removal of NH4Cl was used to induce an acid load in order to activate the pHi regulatory mechanisms.23 Because HCO3--free solutions were used in the present study, mainly Na+-H+ exchange was functional during pHi recovery. Nigericin calibration solutions used in the present study have been described elsewhere.17 BAPTA-AM was purchased from Molecular Probes. Calmidazolium and the protein kinase inhibitor KN-62 were from Sigma and were added (from stock solutions in dimethyl sulfoxide) to Tyrode's solution immediately before use (final concentration of dimethyl sulfoxide, <0.1%).
Loading of Cardiac Cells With BAPTA-AM
In experiments designed to investigate the role of Ca2+ in the Na+-H+ exchange modulation, myocytes were incubated for 30 minutes in the presence of 25 µmol/L BAPTA-AM. Cells were then allowed to hydrolyze the ester for at least 1 hour before the beginning of the investigation. CaCl2 was omitted in the external Tyrode's solution. Using indo 1loaded cardiac cells, Puceat et al24 have previously shown that such a concentration of BAPTA-AM and the BAPTA-loading protocol efficiently prevent a rise in free [Ca2+]i.
Measurement of pHi
The pHi of single isolated myocytes was monitored using the pH-sensitive fluorescent dye carboxy-SNARF-1 (Molecular Probes).25 Cells were loaded with SNARF by incubating them in a 5 µmol/L solution of the acetoxymethyl ester for 10 minutes at room temperature.
Carboxy-SNARF-1 fluorescence from individual cells was measured with an inverted microscope (Nikon Diaphot) converted to epifluorescence. SNARF-loaded cells were excited with light at 515 nm, and the resulting fluorescence at 590 and 640 nm was measured using two photomultiplier tubes (Nikon). The signals were then digitized at 0.5 kHz (CED 1401 intelligent interface, Cambridge Electronic Design) and stored for later analysis on the hard disk of a computer. The emission ratio 590/640 obtained from intracellular SNARF was calculated and converted to a linear pH scale by use of in situ calibration data obtained at the end of the experiment using the nigericin technique described elsewhere.25 26 Finally, the calibrated pHi signal was averaged over 0.5-second intervals.
Estimation of ßi at Different pHi Levels
The method used to estimate ßi has been described previously.17 27 Briefly, a stepwise reduction of external NH4Cl (from 20 mmol/L) was applied to a selected myocyte. Each reduction in NH4+ resulted in the generation of intracellular H+, which was due to dissociation of NH4+ into H+ ions and NH3, with subsequent efflux of NH3. The resultant changes in pHi were used to estimate ßi as follows:
![]() |
Calculation of Sarcolemmal JeH
Details of the method for calculating JeH during pHi recovery in ventricular myocytes have been described previously.17 Briefly, JeH was estimated using the following equation: JeH=ßTxdpHi/dt, where ßT is the total intracellular buffering power and dpHi/dt is the rate of pHi recovery at any given pHi. In HEPES-buffered medium, ßT equals ßi (which was empirically estimated for both normal and diabetic cells in the present study).
Statistics
All data are quoted as mean±SEM along with the number of observations (n). Statistical significance was estimated by Student's t test or ANOVA followed by the Student-Newman-Keuls test to locate differences between groups. Differences were considered significant at a level of P<.05.
| Results |
|---|
|
|
|---|
|
Since HEPES was used as an extracellular buffer, Na+-H+ exchange was the main mechanism regulating pHi after the acid load.17 In order to appreciate the effect of diabetes on the JeH carried by Na+-H+ exchange (JeH=ßixdpHi/dt), we first estimated ßi, over the pHi range of 6.85 to 7.45, using the stepwise removal of external NH4Cl (from 20 mmol/L; see "Materials and Methods"). The procedure was conducted on the two groups of myocytes (normal [n=12] and diabetic [n=11]). The resulting estimates of ßi at various values of pHi are given in Fig 2
. It is clear from this figure that diabetes remained ineffective on ßi in cardiac cells. Moreover, in the pHi range presently tested, ßi appeared to be independent of pHi. Therefore, a mean ßi value of 31.4±0.75 (mmol/L)·pH unit-1 (n=88 individual values from 12 normal plus 11 diabetic cells) was used to calculate JeH through Na+-H+ exchange in both groups of cells.
|
Fig 3
illustrates the relationship between pHi and JeH carried by Na+-H+ exchange calculated in normal (n=32 cells) and diabetic (n=43 cells) myocytes. This figure shows that diabetes results in a leftward shift of the activation curve for Na+-H+ exchange, which means that its activity is significantly decreased (by
42% at pHi 6.9, P<.02) in diabetic rat ventricular myocytes.
|
Effects of pHo on Na+-H+ Exchange Activity in Diabetic Ventricular Myocytes
In cardiac tissue, as well as in other tissues, it has been shown that extracellular H+ ions inhibit Na+-H+ exchange activity.8 9 10 This led us to postulate that in diabetic myocytes, compared with normal myocytes, the observed decrease of Na+-H+ exchange activity might result from a different pHo sensitivity, so that the exchange would be more inhibited at physiological pHo. In order to test this hypothesis, the effects of altering pHo on Na+-H+ exchange were examined in both groups of cells. Fig 4
illustrates the effects of changing pHo from 7.4 to 8.0 (panel A) and from 7.4 to 6.8 (panel B) on pHi in diabetic myocytes. As previously reported for normal cardiac tissue,9 10 increasing pHo resulted in both an increase of steady state pHi and a stimulation of the pHi recovery after the acid load, whereas decreasing pHo exerted opposite effects. These effects on Na+-H+ exchange are further outlined in Fig 5
, which shows the pHi dependence of this exchange at the different pHo levels tested. At pHo 8.0, compared with pHo 7.4 (panel A), the pHi dependence of Na+-H+ exchange in diabetic cells was shifted to the right (thus pointing to a stimulation of the exchange), whereas at pHo 6.8 (panel B), it was shifted to the opposite direction (pointing to an inhibition). No significant difference was apparent in the mean change in steady state pHi recorded upon changing the pH of the superfusing solution between normal and diabetic myocytes (
pHi=-0.28±0.02 [n=6 normal cells] versus -0.28±0.03 [n=8 diabetic cells] pH units, from pHo 7.4 to 6.8;
pHi=0.18±0.01 [n=9 normal cells] versus 0.15±0.01 [n=7 diabetic cells] pH units, from pHo 7.4 to 8.0). With respect to the effects of different pHo levels on Na+-H+ exchange activity, Fig 6
shows that the increase in JeH observed at pHo 8.0 (relative to the control JeH estimated at pHo 7.4 and at pHi 6.9) was not significantly different between both normal and diabetic cells, nor was the decrease observed at pHo 6.8 (relative to control estimated at pHo 7.4 and at pHi 6.75). Therefore, the slowing down of Na+-H+ exchange upon diabetes is unlikely to result from a different pHo sensitivity of the exchanger.
|
|
|
Dependence of Na+-H+ Exchange on Intracellular Ca2+
It has been suggested that Na+-H+ exchange in spontaneously beating cultured rat heart cells is predominantly calmodulin dependent,9 which points to modulation of the exchanger by intracellular Ca2+. Besides, the basal intracellular Ca2+ level has been shown to be significantly decreased in stimulated as well as in quiescent ventricular myocytes isolated from STZ-diabetic rats.15 16 In this context, we hypothesized that the activity of cardiac Na+-H+ exchange might be slowed down in diabetes through an altered modulation by intracellular Ca2+. If the decrease in intracellular Ca2+ did account for the reduced activity of Na+-H+ exchange in diabetic cells, then in the presence of an intracellular Ca2+ buffer, the exchange should have displayed a similar activity in both normal and diabetic myocytes. Cells were thus loaded with BAPTA-AM (25 µmol/L) and superfused with a Ca2+-free solution in order to buffer intracellular Ca2+ ions. Under these conditions, BAPTA-loaded cells had a more acid steady state pHi compared with control (nontreated; see above) cells in both groups (pHi 7.10±0.01, n=11 normal treated cells; pHi 7.13±0.02, n=8 diabetic treated cells; P<.05). This acidification might result from a decrease in basal Na+-H+ exchange activity. Indeed, under steady state conditions, Na+-H+ exchange in ventricular myocytes has been shown to exhibit an activity, though low, in order to counterbalance background acid-loading mechanisms.28 In this context, a slowing down of the exchange would then induce a decrease of steady state pHi. On the other hand, Fig 7A
shows that in a normal cell treated with the Ca2+ chelator, pHi recovery after an acid load was markedly slowed down compared with that recorded in a control normal cell. Similar qualitative effects were observed in the diabetic group. However, in Fig 7B
, it appears that the leftward shift, induced by the BAPTA treatment, of the pHi dependence for Na+-H+ exchange was more pronounced in normal than in diabetic myocytes; at pHi 6.9, JeH was thus decreased by
74% in normal cells versus
58% in diabetic cells. Moreover, it is worth noting that when intracellular Ca2+ was buffered to a low level, JeH carried by the exchange then became identical in both groups. It is important to stress that the BAPTA-loading protocol used in the present study did not significantly change ßi in either group of cells (at pHi 6.9, ßi=33.8 and 31.3 (mmol/L)·pH unit-1 in normal [n=5] and diabetic [n=5] BAPTA-loaded cells, respectively), thus pointing to direct effects on Na+-H+ exchange. Therefore, these results suggest that the alterations in the intracellullar Ca2+ level previously reported in diabetic cells15 16 might, at least in part, account for the slowing down of Na+-H+ exchange.
|
Effects of Inhibiting Calmodulin and Ca2+/CaM Kinase II on Na+-H+ Exchange Activity
The fact that the diabetes-related intracellular Ca2+ level alterations might underlie the change in Na+-H+ exchange activity raised the possibility that alterations in the dependencies of Na+-H+ exchange on calmodulin and/or on Ca2+/CaM kinase II might occur in diabetic myocytes, since both pathways are known to be dependent on the intracellular Ca2+ level. In order to test this hypothesis, we used calmidazolium (1.5 µmol/L)19 and KN-62 (2 µmol/L)20 21 to respectively inhibit calmodulin and CaM kinase II and compared their effects between normal and diabetic groups. Fig 8
shows the typical experiments carried out in order to investigate the effects of these inhibitors on pHi recovery due to Na+-H+ exchange in normal ventricular myocytes. When calmidazolium (panel A) or KN-62 (panel B) was applied to the cell, this resulted in both an acidification of steady state pHi and a clear slowing of pHi recovery following an acid load, thus pointing to a slowing down of Na+-H+ exchange. This slowing is further stressed in Fig 9
, where the pHi dependence of Na+-H+ exchange is significantly shifted to the left by both inhibitors. Similar qualitative effects were observed in diabetic myocytes. However, whereas the degree of inhibition by calmidazolium was not different between both normal and diabetic myocytes (Fig 10
), it appeared that KN-62 inhibited JeH through the exchange more markedly in normal myocytes (by
45%, relative to control estimated at pHi 6.85) than in diabetic myocytes (by
17%, relative to control estimated at pHi 6.85; a significant difference has also been found at pHi levels other than 6.85). It is important to point out here that these effects of calmidazolium and KN-62 on steady state pHi and pHi recovery could have involved effects on the background acid loading mechanisms (metabolic H+ production and/or Cl--HCO3- exchange) rather than effects on Na+-H+ exchange. In order to rule out such a hypothesis, we tested the effects of both inhibitors on pHi when Na+-H+ exchange was blocked by the application of 1 mmol/L amiloride. As expected, this maneuver elicited a slow decrease of steady state pHi. However, under these conditions, addition of either calmidazolium or KN-62 to the superfusion solution did not change the rate of pHi decrease despite the inhibition of Na+-H+ exchange (data not shown). Therefore, this indicated that (1)-calmidazolium and KN-62 per se did not acidify the cells via effects on background acid loading mechanisms, and (2) the effects of these inhibitors on steady state pHi and pHi recovery following an acid load were due to inhibition of Na+-H+ exchange. In conclusion, taken altogether, these results are in favor of alterations in the modulation by CaM kinase II of Na+-H+ exchange in ventricular myocytes isolated from diabetic rat hearts.
|
|
|
| Discussion |
|---|
|
|
|---|
The activity of the ubiquitous or "housekeeping" form of Na+-H+ exchanger (the NHE-1 type, which is the major isoform in the myocardium)29 has been shown to rely on the inward Na+ gradient30 and on intracellular and extracellular H+ ions.8 9 10 30 Several other factors control the activity of the exchanger, such as membrane composition and fluidity,31 growth factors,32 neurotransmitters,33 and second messengers.34 35
In this context, several cellular alterations associated with diabetes might account for the depressed activity of Na+-H+ exchange. For instance, the altered membrane composition,36 through a change in the microenvironment of the exchanger, may induce a shift of its affinity for extracellular and intracellular H+ and Na+. Extracellular H+ ions have been shown to exert an inhibitory action on the cardiac exchanger.10 A diabetes-induced change of the pHo dependence would thus appear to be a good candidate to underlie Na+-H+ exchange depression. However, the present results are not in favor of such a hypothesis. Indeed, we have found that an increase or a decrease in the pH of the superfusing solution elicited similar relative (to control) changes in steady state pHi and in JeH carried by the exchanger in both normal and diabetic myocytes (Fig 6
). It is worth noting that we have previously detected an increase in aiNa in diabetic papillary muscles.7 This increase may well contribute to the depressed activity of the exchanger through a decrease of the transmembrane Na+ gradient. On the other hand, the increased aiNa itself could also play an important and direct inhibitory role, possibly by competing with H+ binding to the internal transport site of the exchanger.37 However, such a role remains to be demonstrated in cardiac tissue.
Alterations in homeostasis of intracellular Ca2+ have been recently demonstrated in diabetic cardiomyopathy, leading to a decrease in [Ca2+]i in quiescent or stimulated myocytes.15 16 Although not yet established in the heart, recent reports have shown that the isoform NHE-1 of the Na+-H+ exchanger is modulated by intracellular Ca2+, so that increasing [Ca2+]i induces a stimulation of the exchange.14 In this context, we have supposed that the reduced [Ca2+]i level related to diabetes might be responsible for the depressed Na+-H+ exchange activity. Although the present results do not provide direct evidence in support of this hypothesis, experiments carried out with BAPTA-loaded cells would tend to favor it. Indeed, when intracellular Ca2+ was buffered, JeH carried by Na+-H+ exchange was not only significantly reduced in both normal and diabetic myocytes, but it then became similar in both groups (Fig 7B
). Thus, two interesting and important points can be drawn from these data: (1) the basal activity of Na+-H+ exchange appears to be controlled by the basal level of intracellular Ca2+ in cardiac tissue, and (2) the decrease in activity of Na+-H+ exchange would stem from the diabetes-related alterations in [Ca2+]i level. With respect to the latter point, in order to fully validate this hypothesis, experiments determining that increasing [Ca2+]i stimulates the cardiac exchanger should have been quoted. Unfortunately, under our experimental conditions, such experiments carried out with the Ca2+ ionophore, ionomycin, appeared inconclusive, in that ionomycin was found to elicit effects on pHi recovery independent of external Ca2+ (data not shown).
Recent studies indicate that the control of NHE-1 activity by Ca2+ may go through at least two different pathways: (1) through direct binding of Ca2+/calmodulin to the exchanger and/or (2) through phosphorylation by Ca2+/CaM kinase II. With respect to the first pathway, it has been reported that NHE-1 in fibroblasts is a Ca2+/calmodulin-binding protein.38 After an increase in [Ca2+]i (induced by ionomycin addition), the direct binding of Ca2+/calmodulin to NHE-1 then stimulates the exchange.14 Moreover, it is worth noting that inhibition of calmodulin by either W-7 or trifluoperazine has been shown to impair pHi recovery from an acid load in spontaneously beating cultured rat heart cells.9 On the other hand, Fliegel et al39 have evidence indicating that activation of Ca2+/CaM kinase II results in a direct phosphorylation of the cardiac Na+-H+ exchanger, which might then lead to its activation. In this context, we have tested the effects of calmidazolium, an inhibitor of calmodulin,19 and of KN-62, an inhibitor of CaM kinase II,20 21 on the activity of the cardiac exchanger in normal and diabetic myocytes in order to find out which of these pathways could be affected by diabetes. Whereas it was known that the purified protein of the cardiac Na+-H+ exchange could be directly phosphorylated by CaM kinase II,39 no evidence was so far available concerning the regulation, by this kinase, of the exchanger in a cellular system. To our knowledge, this study is the first to demonstrate that inhibition of CaM kinase II under acid-load conditions results in a significant (by
45%) reduction of Na+-H+ exchange activity in cardiac ventricular myocytes (Figs 9B and 10![]()
). This raises the interesting possibility of a basal control of the cardiac NHE-1 exchange activity by direct CaM kinasedependent phosphorylation. With respect to the HCO3--dependent acid extruder that works in parallel with Na+-H+ exchange in physiological buffer solution,17 preliminary results indicate that this mechanism is not under control of the CaM kinase II pathway.40 This suggests that under physiological conditions, any agonist that activates this pathway might influence pHi regulation after an acid load through an effect on mainly Na+-H+ exchange. It could be argued that the action of KN-62 on Na+-H+ exchange would involve unspecific effects on [Ca2+]i rather than effects on CaM kinase II. Although [Ca2+]i was not recorded in the present study, one could have expected an increase in [Ca2+]i due to the intracellular acidification elicited by the application of KN-62. Under such conditions and according to our hypothesis (ie, a regulation of the exchanger by Ca2+), a stimulation of Na+-H+ exchange would have occurred. That was clearly not the case. Comparison of the effects of KN-62 between normal and diabetic myocytes shows that the regulatory pathway involving CaM kinase II is most likely affected by diabetes (since KN-62 reduced Na+-H+ exchange activity by only
17% in diabetic myocytes compared with
45% in normal cells), thus supporting the hypothesis that the decrease in steady state [Ca2+]i may alter the Ca2+/CaM kinase II activity. However, whether this pathway is affected because of the decrease in basal [Ca2+]i related to diabetes15 16 and/or because of alterations in CaM kinase II activity remains to be fully elucidated. Moreover, it would be interesting to quantify Na+-H+ exchanger phosphorylation in both groups in order to readily confirm the involvement of this process. In this respect, it is worth noting that a recent report has suggested that the elevated Na+-H+ exchanger activity in lymphoblasts from human hypertensive patients may be related to increased exchanger phosphorylation.41 In the present work, the results obtained with calmidazolium appear rather intriguing. As expected, we found that inhibition of calmodulin resulted in a negative effect on Na+-H+ exchange in ventricular myocytes. However, this effect was found to be identical in normal and diabetic cells, whereas some differences could have been expected because CaM kinase II is known to depend on calmodulin. The absence of different effects of calmidazolium between both groups of cells could come from the use of a too-low dose (1.5 µmol/L). In this regard, it should be emphasized here that Weissberg et al9 have found a nearly complete inhibition of cardiac Na+-H+ exchange with 200 µmol/L W-7 and 60 µmol/L trifluoperazine, two other calmodulin inhibitors, versus an inhibition by
40% with 1.5 µmol/L calmidazolium in the present work (we have also tested a higher dose of calmidazolium [5 µmol/L] in normal cells, but a toxic effect was then observed). Clearly, further work will be required to clarify this point.
In summary, the present study shows that since intracellular intrinsic buffering power, ßi, remains unaffected by diabetes, this pathological state is clearly associated with a significant decrease of Na+-H+ exchange activity in rat isolated ventricular myocytes. This decrease may result from the diabetes-related alterations in [Ca2+]i level, since buffering of intracellular Ca2+ was shown to abolish differences between both groups of cells. An altered CaM kinase IIdependent phosphorylation of the exchanger might underlie this effect, although this does not rule out any other alterations, such as a pretranslational modification of NHE-1 associated with diabetes.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received August 12, 1996; accepted November 7, 1996.
| References |
|---|
|
|
|---|
2. Fliegel L, Frohlich O. The Na+/H+ exchanger: an update on structure, regulation and cardiac physiology. Biochem J. 1993;296:273-2853.
3.
Karmazyn M, Moffat MP. Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 1993;27:915-924.
4. Lagadic-Gossmann D, Chesnais JM, Feuvray D. Intracellular pH regulation in papillary muscle cells from streptozotocin diabetic rats: an ion-sensitive microelectrode study. Pflugers Arch. 1988;412:613-617.[Medline] [Order article via Infotrieve]
5.
Pierce GN, Ramjiawan B, Dhalla NS, Ferrari R. Na+-H+ exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol. 1990;258:H255-H261.
6. Khandoudi N, Bernard M, Cozzone P, Feuvray D. Intracellular pH and role of Na+/H+ exchange during ischaemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res. 1990;24:873-878.[Medline] [Order article via Infotrieve]
7. Lagadic-Gossmann D, Feuvray D. Intracellular sodium activity in papillary muscle from diabetic rat hearts. Exp Physiol. 1991;76:147-149.[Abstract]
8.
Aronson PS, Suhm MA, Nee J. Interaction of external H+ with the Na+/H+ exchanger in renal microvillus membrane vesicles. J Biol Chem. 1983;258:6767-6771.
9.
Weissberg PL, Little PJ, Cragoe EJ Jr, Bobik A. The pH of spontaneously beating cultured rat heart cells is regulated by an ATP-calmodulindependent Na+/H+ antiport. Circ Res. 1989;64:676-685.
10.
Vaughan-Jones RD, Wu M-L. Extracellular H+ inactivation of Na-H exchange in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1990;428:441-466.
11.
Vicentini LM, Villereal ML. Activation of Na+/H+ exchange in cultured fibroblasts: synergism and antagonism between phorbol ester, Ca2+ ionophore, and growth factors. Proc Natl Acad Sci U S A. 1985;82:8053-8056.
12.
Grinstein S, Cohen S. Cytoplasmic [Ca2+] and intracellular pH in lymphocytes. J Gen Physiol. 1987;89:185-213.
13.
Hendey B, Mamrack MD, Putnam RW. Thrombin induces a calcium transient that mediates an activation of the Na+/H+ exchanger in human fibroblasts. J Biol Chem. 1989;264:19540-19547.
14.
Wakabayashi S, Bertrand B, Ikeda T, Pouyssegur J, Shigekawa M. Mutation of calmodulin-binding site renders the Na+/H+ exchanger (NHE1) highly H+-sensitive and Ca2+ regulation-defective. J Biol Chem. 1994;269:13710-13715.
15. Noda N, Hayashi H, Miyata H, Suzuki S, Kobayashi A, Yamazaki N. Cytosolic Ca2+ concentration and pH of diabetic rat myocytes during metabolic inhibition. J Mol Cell Cardiol. 1992;24:435-446.[Medline] [Order article via Infotrieve]
16.
Lagadic-Gossmann D, Buckler KJ, Le Prigent K, Feuvray D. Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats. Am J Physiol. 1996;270:H1529-H1537.
17.
Lagadic-Gossmann D, Buckler KJ, Vaughan-Jones RD. Role of bicarbonate in pH recovery from intracellular acidosis in the guinea-pig ventricular myocyte. J Physiol (Lond). 1992;458:361-384.
18.
Roos A, Boron WF. Intracellular pH. Physiol Rev. 1981;61:296-434.
19. Veigl ML, Klevit RE, Sedwick WD. The uses and limitations of calmodulin antagonists. Pharmacol Ther. 1989;44:191-239.
20.
Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H. KN-62,1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem. 1990;265:4315-4320.
21.
Okazaki K, Ishikawa T, Inui M, Tada M, Goshima K, Okamoto T, Hidaka H. KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes. J Pharmacol Exp Ther. 1994;270:1319-1324.
22.
Jourdon P, Feuvray D. Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol (Lond). 1993;470:411-429.
23.
Boron WF, De Weer P. Intracellular pH transients in squid giant axons caused by CO2, NH3 and metabolic inhibitors. J Gen Physiol. 1976;67:91-112.
24. Puceat M, Clement O, Scamps F, Vassort G. Extracellular ATP-induced acidification leads to cytosolic calcium transient rise in single rat cardiac myocytes. Biochem J. 1991;274:55-62.
25. Buckler KJ, Vaughan-Jones RD. Application of a new pH-sensitive fluoroprobe (carboxy-SNARF-1) for intracellular pH-measurement in small isolated cells. Pflugers Arch. 1990;417:234-239.[Medline] [Order article via Infotrieve]
26. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumour cells utilising spectroscopic probes generated in situ. Biochemistry. 1979;18:2210-2218.[Medline] [Order article via Infotrieve]
27.
Vaughan-Jones RD, Wu M-L. Intracellular intrinsic buffering power varies with pHi in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1990;425:429-448.
28. Lagadic-Gossmann D, Vaughan-Jones RD. Background acid loading in guinea-pig isolated ventricular myocyte. J Mol Cell Cardiol. 1993;25:S29. Abstract.
29. Fliegel L, Dyck JRB. Molecular biology of the cardiac sodium/hydrogen exchanger. Cardiovasc Res. 1995;29:155-159.[Medline] [Order article via Infotrieve]
30. Mahnensmith RL, Aronson PS. The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res. 1985;57:773-788.
31. Dudeja PK, Foster ES, Brasitus TA. Modulation of rat distal colonic brush-border membrane Na+-H+ exchange by dexamethasone: role of lipid fluidity. Biochim Biophys Acta. 1987;905:485-493.[Medline] [Order article via Infotrieve]
32.
Paris S, Pouyssegur J. Growth factors activate the Na+/H+ antiporter in quiescent fibroblasts by increasing its affinity for intracellular H+. J Biol Chem. 1984;259:10989-10994.
33. Puceat M, Vassort G. Neurohumoral modulation of intracellular pH in the heart. Cardiovasc Res. 1995;29:178-183.[Medline] [Order article via Infotrieve]
34. Lagadic-Gossmann D, Vaughan-Jones RD, Richmond P. Effects of elevating cAMP on acid extrusion in the guinea-pig isolated ventricular myocyte. J Physiol (Lond). 1993;459:418P. Abstract.
35. Wu M-L, Vaughan-Jones RD. Effect of metabolic inhibitors and second messengers upon Na+-H+ exchange in the sheep cardiac Purkinje fibre. J Physiol (Lond). 1994;478.2:301-313.
36.
Pierce GN, Kutryk MJB, Dhalla NS. Alterations in Ca2+ binding by and composition of cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A. 1983;80:5412-5416.
37.
Grinstein S, Goetz JD, Rothstein A. 23Na+ fluxes in thymic lymphocytes, II: amiloride sensitive Na+/H+ exchange pathway: reversibility of transport and asymmetry of the modifier site. J Gen Physiol. 1984;84:585-600.
38.
Bertrand B, Wakabayashi S, Ikeda T, Pouyssegur J, Shigekawa M. The Na+/H+ exchanger isoform (NHE1) is a novel member of the calmodulin-binding proteins: identification and characterization of calmodulin-binding sites. J Biol Chem. 1994;269:13703-13709.
39. Fliegel L, Walsh MP, Singh D, Wong C, Barr A. Phosphorylation of the C-terminal domain of the Na+/H+ exchanger by Ca2+/calmodulin-dependent protein kinase II. Biochem J. 1992;282:139-145.
40. Le Prigent K, Lagadic-Gossmann D, Feuvray D. Na+-HCO3- symport activity in diabetic ventricular myocytes. J Mol Cell Cardiol. 1996;28:A67. Abstract.
41.
Ng LL, Sweeney FP, Siczkowski M, Davies JE, Quinn PA, Krolewski B, Krolewski AS. Na+-H+ antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension. 1995;25:971-977.
This article has been cited by other articles:
![]() |
A. Darmellah, C. Rucker-Martin, and D. Feuvray ERM proteins mediate the effects of Na+/H+ exchanger (NHE1) activation in cardiac myocytes Cardiovasc Res, February 1, 2009; 81(2): 294 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Segalen, S. L. Longnus, D. Baetz, L. Counillon, and E. Van Obberghen 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Reduces Glucose Uptake via the Inhibition of Na+/H+ Exchanger 1 in Isolated Rat Ventricular Cardiomyocytes Endocrinology, April 1, 2008; 149(4): 1490 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mattiazzi, L. Vittone, and C. Mundina-Weilenmann Ca2+/calmodulin-dependent protein kinase: A key component in the contractile recovery from acidosis Cardiovasc Res, March 1, 2007; 73(4): 648 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baetz, R. S. Haworth, M. Avkiran, and D. Feuvray The ERK pathway regulates Na+-HCO3- cotransport activity in adult rat cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2102 - H2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. An, S. G. Varadarajan, A. Camara, Q. Chen, E. Novalija, G. J. Gross, and D. F. Stowe Blocking Na+/H+ exchange reduces [Na+]i and [Ca2+]i load after ischemia and improves function in intact hearts Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2398 - H2409. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. King, R. J. Sidell, J. R. Wilding, G. K. Radda, and K. Clarke Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1173 - H1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, S. Gunasegaram, S. E. Harding, and M. Avkiran Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium J. Am. Coll. Cardiol., August 1, 2000; 36(2): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Haworth, J. Sinnett-Smith, E. Rozengurt, and M. Avkiran Protein kinase D inhibits plasma membrane Na+/H+ exchanger activity Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1202 - C1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Le Prigent, D. Lagadic-Gossmann, E. Mongodin, and D. Feuvray HCO−3-dependent alkalinizing transporter in adult rat ventricular myocytes: characterization and modulation Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2596 - H2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Frohlich and M. Karmazyn The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease Cardiovasc Res, November 1, 1997; 36(2): 138 - 148. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |